Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1

Conditions

Neoplasms 2Febrile Neutropenia 2Neutropenia 1Hematologic Neoplasms 1

Interventions

pembrolizumab 1281Specimen Handling 927Carboplatin 835Magnetic Resonance Spectroscopy 834Cyclophosphamide 809Cisplatin 733Nivolumab 683Paclitaxel 638Radiotherapy 614Gemcitabine 582Biopsy 558Bevacizumab 482Dexamethasone 446fludarabine 411Docetaxel 385venetoclax 371Oxaliplatin 368Capecitabine 364Fluorouracil 360atezolizumab 346durvalumab 340Rituximab 334Drug Therapy 332Doxorubicin 319Blood Specimen Collection 317Radiosurgery 317Standard of Care 311Pemetrexed 307Ipilimumab 306Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Amikacin × 1 year × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed
55 enrolled
Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡